NCT06576128 Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions
| NCT ID | NCT06576128 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | Anesthesiology |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-09-10 |
| Primary Completion | 2026-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-09-10 with a primary completion date of 2026-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sensory innervation of the femoral region which is the entry point for endovascular cardiac interventions such as coronary angiography,cardiac catheterization and percutaneous coronary intervention is complex.It is thought that the ilioinguinal and iliohypogastric nerves contribute mostly.With transversus abdominis plane block(TAPB),it is planned to provide analgesia by creating a block in these nerve branches that contribute to the sensory innervation of the intervention area.In addition;it was aimed to investigate patient's and physician's satisfaction during the procedure.
Eligibility Criteria
Inclusion Criteria: * The patient is over 18 years of age * Coronary angiography, cardiac catheterization and percutaneous coronary intervention will be applied to the patient, * The above-mentioned procedures will be taken under elective conditions, * Providing an optimal image when imaging the patient with ultrasound, * INR\< 1.5 * If the patient gives consent, S/he will be included in the study. Exclusion Criteria: * Patients under 18 years of age, * Patients treated under emergency conditions, * morbid obesity (BMI\>35 kg/m2), * pregnant women, * New York Heart Association (NYHA) stage 4 patients with advanced decompensated heart failure, * Patients with symptoms such as redness, temperature increase, infection, hematoma in the application area before the procedure, * Patients with a history of allergy to local anesthetics, * Patients who cannot be communicated, * Those with severe psychosis or progressive neurological deficits and muscle disease, * Patients who do not consent to the application will be excluded from the study.
Contact & Investigator
Kerem Erkalp
STUDY CHAIR
Proffessor
Frequently Asked Questions
Who can join the NCT06576128 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anesthesiology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06576128 currently recruiting?
Yes, NCT06576128 is actively recruiting participants. Contact the research team at gozde.altun@iuc.edu.tr for enrollment information.
Where is the NCT06576128 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06576128 clinical trial?
NCT06576128 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Kerem Erkalp at Proffessor. The trial plans to enroll 100 participants.